{
  "id": "31d6106a450c872f",
  "title": "Abpro and Celltrion , Inc . Announce U . S . FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP - 102 / CT - P72",
  "description": "20260106T130000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/01/06/tmt-newswire/globenewswire/abpro-and-celltrion-inc-announce-us-fda-ind-clearance-for-lead-multispecific-antibody-cancer-candidate-abp-102-ct-p72/2253559",
  "published_at": "20260106T130000Z",
  "fetched_at": "2026-01-07T00:22:40.638561+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/01/06/tmt-newswire/globenewswire/abpro-and-celltrion-inc-announce-us-fda-ind-clearance-for-lead-multispecific-antibody-cancer-candidate-abp-102-ct-p72/2253559",
    "url_mobile": "https://www.manilatimes.net/2026/01/06/tmt-newswire/globenewswire/abpro-and-celltrion-inc-announce-us-fda-ind-clearance-for-lead-multispecific-antibody-cancer-candidate-abp-102-ct-p72/2253559/amp",
    "title": "Abpro and Celltrion , Inc . Announce U . S . FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP - 102 / CT - P72",
    "seendate": "20260106T130000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/06/889311.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}